发明名称 EPO PRIMARY RESPONSE GENE1, EPRG1
摘要 PROBLEM TO BE SOLVED: To obtain a new polypeptide, comprising EPRG1 polypeptides having a high identity to a specific amino acid sequence and useful for the treatment, diagnosis or the like of anemia, polycythemia, cancer, neutropenia, AIDS, autoimmune diseases, inflammatory diseases or the like. SOLUTION: This new isolated EPRG1 polypeptide is selected from a polypeptide having at least 70% identity, 80% identity, 90% identity or 95% identity to an amino acid sequence represented by the formula over the entire length thereof, a polypeptide containing the amino acid sequence represented by the formula and a polypeptide comprising the amino acid sequence represented by the formula and is useful for treatment, diagnosis or the like of anemia, polycythemia, cancer, neutropenia, AIDS, drug-induced anemias, myelosuppression, autoimmune diseases, inflammatory diseases or the like. The polypeptide is obtained by providing a polynucleotide by the standard cloning and screening from a cDNA library derived from a human bone marrow and a hematopoietic cell, then integrating the resultant polynucleotide into a vector and expressing the polypeptide in a host cell.
申请公布号 JPH11103867(A) 申请公布日期 1999.04.20
申请号 JP19980161262 申请日期 1998.05.07
申请人 SMITHKLINE BEECHAM CORP 发明人 LORD KENNETH A;DILLON SUSAN B
分类号 G01N33/566;A61K38/22;A61K39/395;A61K45/00;A61K48/00;A61P7/06;A61P11/00;A61P29/00;A61P35/00;A61P37/00;A61P37/08;C07K14/47;C07K14/575;C07K16/18;C12N15/09;C12P21/02;C12P21/08;C12Q1/68 主分类号 G01N33/566
代理机构 代理人
主权项
地址